All News

Malar,rash,SLE, Lupus

Anifrolumab Reduces Lupus Flares

Jack Cush, MD

Anifrolumab has been studied in two large phase 3 trials in systemic lupus erythematosus (SLE) patients; pooled data from both the TULIP-1 and TULIP-2 trials were used to show that anifrolumab reduces flares in patients with moderate to severe SLE. 

Read Article
RheumNow Podcast square

RheumNow Podcast – BandAids for Rheumatologists (5.14.2021)

Jack Cush, MD

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com - a website for rheumatologists, by rheumatologists.



We love Rheumatology!

Read Article
RNL, over, microphone

RheumNow Live 2021 Now Available for All

Jack Cush, MD

RheumNow Live (RNL) for 2021 was held March 20 - 21 in Fort Worth, TX, and now all can partake in the meeting - by video, podcast or by signing up for Tuesday Nite Rheumatology (TNR).

Read Article
DPGN, lupus, nephritis, GN, glomerulonephritis, biopsy, kidney

AURORA-1: Voclosporin Efficacy in Lupus Nephritis

Jack Cush, MD

Lancet has published the results of the AURORA-1 trial, wherein the calcineurin inhibitor, voclosporin, was tested in a placebo controlled trial of lupus nephritis and shown to be effective at inducing a complete renal response.

Read Article
blood, level, numbers, data, calculation

Higher Hydroxychloroquine Blood Levels Reduces Thrombosis Risk in Lupus

Jack Cush, MD

Petri and colleagues have published that measuring hydroxychloroquine (HCQ) blood levels can be useful in systemic lupus erythematosus (SLE), as low levels are associated with an increased thrombotic risk in SLE.

Read Article
RheumNow Podcast square

RheumNow Podcast – Falling or Falling in Love?

Jack Cush, MD

Dr. Jack Cush reviews the best journal articles from the past week on RheumNow.com.

Read Article
If any rheums out there have not watched the vaccine town hall by @ACRheum I highly recommend it. A master class on vaccine counseling by @gradydoctor ! Thank you! Thanks @IreneBlancoMD and @DrDavidKarp https://t.co/4ofQVkjKYz via @YouTube

Links:

Jilaine Bolek Berquist BolekBerqui ( View Tweet)

Textbooks say fever is common in lupus ("36%–86%") BUT IT IS NOT! Lupus is cause of FUO in 5%; Fever is seen in a minority of SLE onsets; Fever occurs w/ SLE complications - vasculitis, pneumonitis/serositis/alveolar hem, CNS, & INFECTION! https://t.co/KvZeo6Q1WY

Links:

Dr. John Cush RheumNow ( View Tweet)

Dr. Jack Cush - Hemoptysis in Lupus https://t.co/SjBazKiTW8 #LupusAwarenessMonth https://t.co/6z2R456Clm

Links:

Dr. John Cush RheumNow ( View Tweet)
International survey by the World Lupus Federation of 6,100 lupus pts from over 85 countries shows 50% reporting decreased access to lupus healthcare; including /rheumatologist 36%, medical tests 29%, infusions 24%, meds 17% https://t.co/5tlbiP65gf

Links:

Dr. John Cush RheumNow ( View Tweet)

Dr. Janet Pope - Comorbidities in SLE From ACR 2019 https://t.co/1BjfVOfL4i #LupusAwarenessMonth https://t.co/apjrwa36dA

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Mike Putman - TULIP Trials - Anifrolumab in SLE https://t.co/cqZiulDMFm #LupusAwarenessMonth https://t.co/kNKLUSOKWp

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Janet Pope - Comorbidities in SLE From ACR 2019 https://t.co/1BjfVOfL4i https://t.co/CRqUKeYUmi

Links:

Dr. John Cush RheumNow ( View Tweet)
Dr. Kathryn Dao - Lupus Pearls from ACR 2019 https://t.co/JDlfjAO0xe #LupusAwarenessMonth https://t.co/1ZiZiNvYhv

Links:

Dr. John Cush RheumNow ( View Tweet)
It's #LupusAwarenessMonth --review our lupus coverage from the archives. Dr. Janet Pope - New SLE criteria and guidelines and approach to refractory Lupus patients From RWCS 2020 https://t.co/eufxObGFic https://t.co/pReB8aPHlp

Links:

Dr. John Cush RheumNow ( View Tweet)
News Feature: Higher Hydroxychloroquine Blood Levels Reduces Thrombosis Risk in Lupus Petri and colleagues have published that measuring HCQ blood levels is useful in SLE patients as low levels are associated with thrombosis in SLE. https://t.co/jAXUJoM2Pa https://t.co/h8KonZRnX8

Links:

Dr. John Cush RheumNow ( View Tweet)
News Feature: Childhood Lupus May Hamper Adult Careers Long-term outcomes of kids with cSLE are uncommon, but this cSLE cohort analysis suggests that SLE significantly impacts their future education, vocation, and employment as they reach adulthood. https://t.co/RQc4JD3BIt https://t.co/y5LboAUsw3

Links:

Dr. John Cush RheumNow ( View Tweet)
#LupusAwarenessMonth Dr. Kathryn Dao - Risk of Hydroxychloroquine Retinal Toxicity From ACR 2020 https://t.co/7BCVvMOm0T https://t.co/PhHubO7rxG

Links:

Dr. John Cush RheumNow ( View Tweet)
#LupusAwarenessMonth Dr. Michelle Petri - Best Practices in Testing for Antiphospholipid Syndrome (LAC wins) From ACR 2020 https://t.co/IyeRDzw4BC https://t.co/nSkauHf29T

Links:

Dr. John Cush RheumNow ( View Tweet)
News Feature: Childhood Lupus May Hamper Adult Careers Long-term outcomes of kids with cSLE are uncommon, but this cSLE cohort analysis suggests that SLE significantly impacts their future education, vocation, and employment as they reach adulthood. https://t.co/RQc4JD3BIt https://t.co/l0ZQWHNFng

Links:

Dr. John Cush RheumNow ( View Tweet)
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×